Hear professionals discuss diagnosing tardive dyskinesia and treatment. AUSTEDO can cause serious side effects in people with Huntington’s disease, including: depression, suicidal …

The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia. Adverse …

Dec 18, 2025 · Learn about uses, side effects, and more for Austedo (deutetrabenazine), a drug that treats tardive dyskinesia and chorea related to Huntington’s disease.

Aug 20, 2025 · Austedo (deutetrabenazine) is a prescription medicine used to treat chorea associated with Huntington's disease and tardive dyskinesia (TD), which are involuntary …

AUSTEDO XR and AUSTEDO do not cure the cause of the involuntary movements, and it does not treat other symptoms of Huntington’s disease, such as problems with thinking or emotions. …

While the recommendations in the above table can prove effective for many individuals with TD, there have been numerous additional treatments studied to determine their effectiveness in …

Jul 16, 2024 · Austedo (aw-STED-oh) was approved in 2017 and is the first medicine approved to treat both tardive dyskinesia and chorea caused by Huntington’s disease.

Sep 21, 2025 · The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis …

May 30, 2024 · The FDA has approved Austedo XR as a once-daily pill treatment option for tardive dyskinesia and Huntington disease chorea control.

Deutetrabenazine, sold under the brand name Austedo, is a vesicular monoamine transporter 2 inhibitor which is used for the treatment of chorea associated with Huntington's disease and …